- New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future
[作者:Nannini, M; Biasco, G; Maleddu, A; Pantaleo, MA,期刊:Expert Opinion on Therapeutic Targets, 页码:803-815 , 文章类型: Review,,卷期:2011年15-7]
- Areas covered: The first aim of this review is to describe new targets and drugs in GISTs, alone or in combination, both in pre-clinical and clinical settings. The second aim is to discuss the criticism in this field, th...
- Overcoming drug resistance in pancreatic cancer
[作者:Long, J; Zhang, YQ; Yu, XJ; Yang, JX; LeBrun, DG; Chen, CY; Yao, QZ; Li, M,期刊:Expert Opinion on Therapeutic Targets, 页码:817-828 , 文章类型: Review,,卷期:2011年15-7]
- Areas covered: Previous studies have indicated various mechanisms of drug resistance in pancreatic cancer, including changes in individual genes or signaling pathways, the influence of the tumor microenvironment, and the...
- Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy
[作者:Heinzle, C; Sutterluty, H; Grusch, M; Grasl-Kraupp, B; Berger, W; Marian, B,期刊:Expert Opinion on Therapeutic Targets, 页码:829-846 , 文章类型: Review,,卷期:2011年15-7]
- Areas covered : Information from these sources as well as ongoing work from the authors' groups is used to outline the physiological functions of FGF signaling and to highlight how the high oncogenic effects of deregulat...
- NK-1 as a melanoma target
[作者:Munoz, M; Bernabeu-Wittel, J; Covenas, R,期刊:Expert Opinion on Therapeutic Targets, 页码:889-897 , 文章类型: Review,,卷期:2011年15-7]
- Areas covered: This review provides an overview of the underlying mechanism of action of the SP/NK-1 receptor system, and NK-1 receptor antagonists in human melanoma, over the last 7 years. Expert opinion: In stages III ...
|